Review of Chromatographic Bioanalytical Assays for the Quantitative Determination of Marine-Derived Drugs for Cancer Treatment

  • Lotte van Andel
  • , Hilde Rosing
  • , Jan Hm Schellens
  • , Jos H Beijnen

Research output: Contribution to journalReview articlepeer-review

Abstract

The discovery of marine-derived compounds for the treatment of cancer has seen a vast increase over the last few decades. Bioanalytical assays are pivotal for the quantification of drug levels in various matrices to construct pharmacokinetic profiles and to link drug concentrations to clinical outcomes. This review outlines the different analytical methods that have been described for marine-derived drugs in cancer treatment hitherto. It focuses on the major parts of the bioanalytical technology, including sample type, sample pre-treatment, separation, detection, and quantification.

Original languageEnglish
Article number246
JournalMarine Drugs
Volume16
Issue number7
DOIs
Publication statusPublished - 23 Jul 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being
  2. SDG 14 - Life Below Water
    SDG 14 Life Below Water

Keywords

  • Animals
  • Antineoplastic Agents/chemistry
  • Aquatic Organisms/chemistry
  • Biological Assay/methods
  • Chromatography, Liquid/methods
  • Drug Discovery/methods
  • Humans
  • Neoplasms/drug therapy

Fingerprint

Dive into the research topics of 'Review of Chromatographic Bioanalytical Assays for the Quantitative Determination of Marine-Derived Drugs for Cancer Treatment'. Together they form a unique fingerprint.

Cite this